Please assess the completion status of the following clinical trial:

Trial Title: A Study to Compare the Safety and Effectiveness of 2 Doses of Levofloxacin Given for Different Time Periods in Patients With Pneumonia

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Diagnosis of community-acquired pneumonia as follows: clinical signs and symptoms of a lower respiratory tract infection and chest-x-ray findings consistent with pneumonia within 24 hours before entry into the study~* At least one of the following: abnormal temperature (high or low) or abnormal white blood cell count~* Previous antibiotic treatment \<= 24 hours or, if the duration of treatment was \>= 72 hours and that therapy failed based on at least 2 of the following: fever within 12 hours of entry into the study, chest x-ray findings have worsened compared to the initial chest-x-ray, white blood cell count is significantly increased, respiratory rate higher than at the start of treatment and \>= 20 breaths per minute or need for supplemental oxygen if not previously needed~* Patients whose infection is acquired in the community or, if in a nursing home, who had been living there \< 14 days~* Fine Class (rating scale used to assess patients' overall condition which includes information such as age, gender, other diseases, physical examination and laboratory findings) score \<= 130 upon admission (patients with Fine Class scores \> 70 but \< = 130 must initially be hospitalized~* Patients with scores of \<= 70 may be treated as outpatients or hospitalized at the discretion of the investigator)~Exclusion Criteria:~* Pneumonia known or suspected to be due to a bacteria resistant to levofloxacin~* Previous allergic or serious reaction to or failed therapy with levofloxacin or similar drugs~* Life expectancy \< 72 hours~* Hospitalized within 2 weeks before entry in the study or within 1 month before entry in the study if treated with antibiotics~* Pneumonia acquired in a hospital~* Cystic fibrosis or other lung disorders~* Receiving chronic steroid treatment~* Received assistance from a machine to breathe within the previous month

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).